实验动物科学 ›› 2020, Vol. 37 ›› Issue (01): 69-.
• 研究进展 • 上一篇 下一篇
出版日期:
发布日期:
Online:
Published:
摘要: 阿尔兹海默症(alzheimer’s disease,AD),是一种中枢神经系统退行性疾病,以老年斑块沉积和神经纤维缠结为主要特征,患者表现为认知能力减退、生活不能自理,该病的预防与治疗已经成为国内外研究的热点。在防治AD的实验研究领域,APP/PS1转基因小鼠模型有着广泛的应用,因为其能较好地反映阿尔兹海默症患者的病理特征、临床表现,是一种较理想的AD动物模型。本文综述近五年来中药对APP/PS1转基因AD小鼠治疗作用的研究进展,以期为后续防治AD的研究提供参考。
关键词: 阿尔兹海默症, APP/PS1转基因小鼠, 中药
Abstract: Alzheimer's disease, is a central nervous system degenerative disease, the senile plaques and neurofibrillary tangles are its main characteristics. Patients with cognitive impairment, they can not take care of themselves. AD is a serious threat to the elder's health and longevity, the disease prevention and treatment has become a hot spot of research at home and abroad. In the field of experimental research on the prevention and treatment of AD, the transgenic mouse model of APP/PS1 is widely used, because it can better reflect the pathological features and clinical manifestations of patients with alzheimer's disease, and is a relatively ideal AD animal model. This paper reviews the past five years of traditional Chinese medicine effective component, Chinese medicine compound of APP ; PS1 transgenic mice AD advances in there search of the rapeutic effects oasto provide reference for subsequent research of prevention and treatment of AD.
Key words: Alzheimer's disease, APP /PSl transgenic mice, traditional Chinese medicine
徐慧琳, 范震, 冯成强. 中药对阿尔兹海默症APP/PS1转基因小鼠的治疗作用研究进展[J]. 实验动物科学, 2020, 37(01): 69-.
0 / / 推荐
导出引用管理器 EndNote|Ris|BibTeX
链接本文: http://www.sydwkx.com/CN/
http://www.sydwkx.com/CN/Y2020/V37/I01/69